Encompass Health Co. (NYSE:EHC) Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.4% in the 4th quarter, Holdings Channel reports. The fund owned 769,716 shares of the company’s stock after acquiring an additional 2,904 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Encompass Health were worth $71,083,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. State Street Corp grew its stake in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock valued at $292,410,000 after purchasing an additional 21,329 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after buying an additional 20,547 shares during the last quarter. Copeland Capital Management LLC increased its stake in shares of Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock worth $119,418,000 after buying an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. raised its holdings in Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after acquiring an additional 156,938 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Up 1.3 %

Encompass Health stock opened at $99.86 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health Co. has a one year low of $72.37 and a one year high of $104.55. The company has a 50-day simple moving average of $96.28 and a 200-day simple moving average of $95.30. The firm has a market capitalization of $10.06 billion, a P/E ratio of 22.39, a P/E/G ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. As a group, equities analysts expect that Encompass Health Co. will post 4.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of recent analyst reports. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Finally, Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.33.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.